Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Gilead scientists prepare and test novel HIV integrase inhibitors

Dec. 18, 2006

Novel antiinfective agents disclosed in recent F2G and Daiichi patents

Dec. 18, 2006

New agents for gastrointestinal disorders reported in recent patents

Dec. 15, 2006

Novel treatment options for metabolic disorders described in recent patent literature

Dec. 15, 2006

Recent patents impart new therapeutic agents for cancer

Dec. 14, 2006

Novel therapeutic agents for hepatitis C virus infection disclosed in recent patent literature

Dec. 14, 2006

Recent patents disclose new therapeutic agents for anxiety, depression, etc.

Dec. 13, 2006

Recent patents report novel analgesic agents

Dec. 13, 2006

New agents for urinary incontinence emerge from Astellas Pharma R&D

Dec. 13, 2006

Novel agents for treating neurological disorders disclosed in recent Neuren and Santhera patents

Dec. 12, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...